caffeic acid phenethyl ester has been researched along with thromboplastin in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (thromboplastin) | Trials (thromboplastin) | Recent Studies (post-2010) (thromboplastin) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 10,540 | 281 | 2,126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhmedov, A; Camici, GG; Gebhard, C; Holy, EW; Largiadèr, S; Lüscher, TF; Stähli, BE; Tanner, FC | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and thromboplastin
| Article | Year |
|---|---|
Caffeic acid phenethyl ester inhibits endothelial tissue factor expression.
Topics: Aorta; Caffeic Acids; Cells, Cultured; Endothelial Cells; Fibrinolytic Agents; Humans; Mitogen-Activated Protein Kinases; Phenylethyl Alcohol; RNA, Messenger; Thromboplastin; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2013 |